Interstitial Lung Disease

Pulsed, inhaled nitric oxide at a higher dose was safe and well tolerated, and resulted in improvements in physical activity and other outcomes in patients at risk for pulmonary hypertension-associated fibrotic interstitial lung disease.

The Healio editors have compiled a list of the most-read pulmonology news published in July.

People with interstitial lung abnormalities have an increased risk for lung cancer and lung cancer mortality, but not other cancers, according to a study published in the European Respiratory Journal.

Methotrexate use by patients with rheumatoid arthritis was not associated with an increased risk for developing interstitial lung disease, according to a study published in European Respiratory Journal.

Understanding the breadth of pulmonary complications among patients with rheumatic disease is critical to total patient care, according to a presenter at the 2020 Interdisciplinary Autoimmune Summit.

Treatment with nintedanib slowed the rate of interstitial lung disease progression in patients with chronic fibrosing ILD and progressive phenotype, irrespective of their underlying ILD diagnosis, according to analysis of the INBUILD trial.

A comprehensive online home monitoring program for patients with idiopathic pulmonary fibrosis did not improve health-related quality of life, but improved patients’ psychological well-being.

Firefighters may have increased risk for interstitial lung disease and autoimmunity as a result of inhalation exposure over years of service.

Inhaled treprostinil was well tolerated and significantly improved exercise capacity and other clinical outcomes over 16 weeks in patients with pulmonary hypertension associated with interstitial lung disease, according to results of the INCREASE study.

Patients with interstitial lung disease demonstrated a higher proportion of comorbidities and rheumatoid arthritis activity, as well as rheumatoid arthritis-related conditions, according to a presenter at the EULAR 2020 Virtual Congress.